Contractile Dysfunction in Sarcomeric Hypertrophic Cardiomyopathy

David H MacIver1, Andrew L Clark2

  • 1Department of Cardiology, Taunton & Somerset Hospital, Musgrove Park, Taunton, UK; Biological Physics Group, School of Physics & Astronomy, University of Manchester, Manchester, UK; Medical Education, University of Bristol, Senate House, Tyndall Avenue, Bristol BS8 1TH, UK.

Insights

Reduced contractile stress, not just hypertrophy, drives hypertrophic cardiomyopathy. Hemodynamic load influences the specific disease pattern, impacting cardiac function and phenotype.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Biomedical Engineering

Background:

  • The mechanisms behind hypertrophic cardiomyopathy (HCM) phenotypes remain debated.
  • Cardiac hypertrophy in conditions like hypertension is typically a compensatory response to normalize wall stress.

Purpose of the Study:

  • To propose that reduced myocardial contractile stress, rather than solely hypertrophy, is a key abnormality in HCM.
  • To investigate how hemodynamic load influences the diverse clinical phenotypes observed in HCM.

Main Methods:

  • The study proposes a theoretical framework based on existing pathophysiological understanding.
  • Analysis of the relationship between contractile stress, cardiomyocyte disarray, and cardiac remodeling.
  • Examination of how different hemodynamic loads might lead to specific HCM patterns.

Main Results:

  • Reduced contractile stress, caused by factors like cardiomyocyte disarray, is suggested as a primary driver of HCM progression.
  • This reduced stress leads to worsening hypertrophy and disarray, despite preserved or enhanced ejection fraction.
  • Hemodynamic load is proposed to dictate the specific phenotype: concentric hypertrophy in hypertension, asymmetric in athletes, and apical in inactive individuals.

Conclusions:

  • HCM pathophysiology may involve a primary deficit in myocardial contractile stress.
  • The interplay between contractile stress, cardiac remodeling, and hemodynamic load determines HCM phenotype.
  • Left ventricular outflow tract obstruction and mitral regurgitation could arise from regional strain disparities and mitral annular rotation.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
652
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
761
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
738
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
783
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each...
18.7K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
18.8K